On Monday, Amazon introduced a new feature that allows anyone to design merchandise using AI, posing an expanded challenge to online merch platforms like Redbubble, Bonfire, Spring, Fourthwall, and ...

There's nothing in sport that fans the flames of excitement as much as a World Cup. We're just less than a week away from the 2026 edition getting underway and it's time to start putting together ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Out-of-state money is fueling ...

Minecraft master Craftee collects unpredictable lucky hearts that grant random powers. Coffee linked to significant new side effect, says massive study Iran targets US with psychological warfare ...

Threat actors in Latin America have begun to use AI agents to facilitate their entire attack chains, from assisting with initial access to generating penetration tools on the fly — and organizations ...

A lot of thought goes into naming a racehorse. Some people take inspiration from the horse’s pedigree, while others make it more personal, naming the horse after something special to the owner: a ...

One of the best parts of the Kentucky Derby is listening to Travis Stone, the Churchill Downs Racetrack announcer, rapidly list off the name of each Kentucky Derby horse. So, what is your Kentucky ...

Firefly custom models analyze your assets to preserve character designs and emulate illustration and photography styles. Firefly custom models analyze your assets to preserve character designs and ...

Josh Finan, the rising British star best known for his recent TV work on shows such as “The Responder” (for which he was BAFTA TV nominated), “The Gentleman,” “Say Nothing” (playing Gerry Adams) and ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...